Jana G Hashash, MD, MSc @JHashashMD Twitter profile

Last Seen Profiles

@bKjAfKR1nobz5d7

@GeoWhatap

@angeIasknife

@danielzaroe

@ThrowGerki

@cukienaknikmati

@bokeplokalmalam

@stw_pdg

@gonzo3249

@KrissyMarg2820

@YellowstoneTV

@__rude22

@Carvalho_Svcer

@ddNNawjbkHZmrGt

@regretanons

@ts_vintage

@dan_mao20

@Brahim

@_sarah_magdy

@iu81i

@Yuran_miwaku

@Sognatore23

@b_hakimiyet

@QuhF30pj58nHZpr

@bokeplokalmalam

@dlPZ4tt7fhfsNwb

@bokeplokalmalam

@WillFlemming

@cukienaknikmati

@excell305

@akrep_kral_

@SpearsAdel84898

@bottomforfat

@i7_ull

@liz__d01

@excell305

Jana G Hashash, MD, MSc

@JHashashMD

4 years

We just received the COVID-19 vaccines in 🇱🇧 and I’m so grateful to be getting my first dose @AUBMC_Official . I was told that if I don’t post my photo, I won’t develop antibodies.... so here’s to a lot of long lasting Abs!! #StickItToCOVID

3

6

186

Jana G Hashash, MD, MSc

@JHashashMD

9 months

🔊🔥Hot off the press @AmerGastroAssn #CPU on Role of Diet 🍽️ 🥘 🥗🍔 in #IBD in @AGA_Gastro ✅Mediterranean diet unless contraindicated 💎Personalization is 🔑 🌟Malnutrition not = to low albumin @JamesLewisGIEpi @BinionMd @AndrewWangMD #jelkins

5

54

163

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Hot off the press! Fecal Calprotectin from Ileostomy Output is Sensitive and Specific for the Prediction of Small Bowel Inflammation in CD @FarrayeIBD @MayoClinicGIHep

Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small...

FC from an ileostomy effluent is a highly sensitive and specific test for the assessment and monitoring of small bowel inflammation and disease recurrence in patients with CD.

pubmed.ncbi.nlm.nih.gov

4

29

126

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Thank you to the @AmJGastro for accepting our work showing that: EHR burden 😓 is real ☑️ IBD and hepatology GI specialists spend ⬆️⬆️ time ⏱️ outside regular work hours on 💻 (pajama time 😴 💤✨🥱) @AmanBaliMD @FarrayeIBD @ibdgijami @MayoClinicGIHep

Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and...

IBD and hepatology specialists and NPPs may have disproportionally high EHR burden. More work is needed to understand differences in provider workload to combat burnout.

pubmed.ncbi.nlm.nih.gov

6

22

119

Jana G Hashash, MD, MSc

@JHashashMD

3 years

I am so incredibly proud of my friend and mentor @MRegueiroMD for being selected as the next DDSI Chair at @ClevelandClinic . This is such a well deserved honor and speaks of his unparalleled dedication and leadership. Hoping to celebrate soon!

1

4

106

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Super proud of our rising GI 🌟 for presenting our research on significance of granuloma in CD at #DDW2022 💠Granuloma on GI tract biopsy is associated with intra-abdominal abscesses and fistula 💠Granuloma is associated with ⬆️ immunomodulator use

3

5

102

Jana G Hashash, MD, MSc

@JHashashMD

2 years

My ❤️ is full seeing med students, residents, fellows, and colleagues present at @AmCollegeGastro with a unifying goal: to improve patient outcome and advance the field of GI. @MayoClinicGIHep @AUBMC_Official @AUB_Lebanon

4

8

102

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Nothing beats catching up with the best of friends @MRegueiroMD ! Thank you @AmCollegeGastro for making this possible!

4

1

98

Jana G Hashash, MD, MSc

@JHashashMD

2 years

New updates on the treatment of moderate to severe #CrohnsDisease available on @UpToDate @MRegueiroMD @SunandaKaneMD

0

15

97

Jana G Hashash, MD, MSc

@JHashashMD

1 year

Very nice to connect with past students, residents, and fellows who are now colleagues at #DDW2023 @AmerGastroAssn #AGAgastrosquad

4

2

93

Jana G Hashash, MD, MSc

@JHashashMD

3 months

Save the date!! Sept 28, 2024! For Updates in IBD conference @MayoClinic FL Great topics Amazing speakers Sun and Fun Sign up @AmCollegeGastro @AmerGastroAssn @CrohnsColitisFn @IBDProNews @FarrayeIBD @ibdgijami @EdwardLoftus2 @MLongMD @Khanna_S @IBDMD

1

20

85

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Reflecting back on the phenomenal & inspirational talk of @AmyOxentenkoMD from #AIBD 2021. Take care of your 4 glass balls! @jensemineriomd @ibddocmaria @MLongMD @IBD_Houston @ibdgijami @IBD_Afzali @SCKimCHP #marladubinsky @DCharabaty @DrJessicaA @AmyLightnerMD @LauraRaffalsMD

2

14

76

Jana G Hashash, MD, MSc

@JHashashMD

2 years

🔊Hot off the press @AGA_CGH #Paxlovid in #IBD ⬇️ hospital🏥 🛏 vs #IBD without💊 #Paxlovid in #IBD ➡️ NO🚫 death/ICU #Paxlovid 🟰in #IBD & no IBD #Lagevrio in #IBD no sig ⬇️ hospital🏥 vs #IBD without💊 ‼️Remember💊 drug-to-drug interaction🔀 @FarrayeIBD @GKochharMD @akMD03

1

21

74

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Absolutely privileged to have worked on @AmerGastroAssn #CPU with @umfoodoc @LinChangMD #lauramanning on Role of Diet in #IBS @AGA_Gastro 💎Multidisciplinary mgmt is 🔑 💎Be aware of disordered eating 💎Most evidence based diet intervention is Low FODMAP 💎Low FODMAP x 3 phases

1

11

70

Jana G Hashash, MD, MSc

@JHashashMD

6 months

Practical Tips on Pain Mgmt in IBD in @AGA_Gastro by @drlauriekeefer et al Persistent abdominal pain in #IBD is common 🔑 Recognize💡& Communicate🗣️ diagnosis 💪 Empower pts to engage in Self-Mgmt 💊 Neuromodulators ok 🤝 Multidisciplinary care is 🙌👌

0

22

61

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Don’t forget to submit your #IBD abstracts to @IBDConference by tonight! @FarrayeIBD @mariannysulbar @ibdgijami @MayoClinicGIHep FL @MRegueiroMD @MLongMD @NMH_SHanauerMD

0

3

59

Jana G Hashash, MD, MSc

@JHashashMD

7 months

Check out brief 🎧 podcast on What you need to know about #diet and nutritional therapies for patients with #IBD 🍎🥗🥑🍓🍒🥬 ⁦ @AmerGastroAssn ⁩ ⁦ @JamesLewisGIEpi ⁩ ⁦ @BinionMd ⁩ ⁦⁦ @AGA_Gastro ⁩

What you need to know about diet and nutritional therapies for IBD patients

In our latest clinical practice update, experts outline 12 best practice advice statements for how to advise your IBD patients on diet.

gastro.org

1

24

57

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Excellent expert review for diagnosis & management of pts with immune checkpoint inhibitor (ICI) colitis and hepatitis #AGA_CPU @AGA_Gastro @AmerGastroAssn @AasmaShaukatMD 🔷Prompt dx & tx 🔷R/O infx diarrhea 🔷Endoscopy pre⬆️dose steroids 🔷Baseline LFTs & before every cycle

0

15

56

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Check out the recently published #AGA_CPU expert review in @AGA_Gastro on Management of IBD in Elderly Pts @AmerGastroAssn @AshwinMDIBD @MGH_GI #GeoffreyNguyen #CharlesBernstein @GastroUManitoba @AasmaShaukatMD @MRegueiroMD

1

12

56

Jana G Hashash, MD, MSc

@JHashashMD

3 years

‼️Always address health care maintenance when seeing pts with #IBD ✅ Checklists available to help 💉vaccinate (inactive vaccines safe regardless of immunosupp) Screen for cancer: cervical, colon, skin Assess mental health Evaluate 🦴 bone health Advise against❌smoking 🚬

1

13

53

Jana G Hashash, MD, MSc

@JHashashMD

3 years

🔊Extremely informative #AGA_CPU on Mgmt of Chronic GI pain in Disorders of Gut-Brain Interaction #DGBI @AGA_CGH @AmerGastroAssn by @drlauriekeefer @alex_ford12399 #CynthiaKo ❌ NO opioids ✅ Early consideration of nonpharmacologic tx 🧑‍⚕️👨‍⚕️ be familiar with effective neuromods

0

23

51

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Screen and get screened for the preventable colorectal cancer #DressinBlueDay #45isthenew50 #ACGWomenInGI @AmCollegeGastro @AmerGastroAssn @MayoClinic @MayoClinicGIHep

1

5

51

Jana G Hashash, MD, MSc

@JHashashMD

2 years

🔊🔥🖨️ @AGA_CGH #AGA_CPU Alpha-gal syndrome ➡️ IgE mediated rxn after ingesting mammalian products 🍔🥩🥛🧀 GI alpha gal = abdominal pain☹️, 🤢/🤮, diarrhea💩 History is 🔑 for dx; alpha-gal Ig-E Abs support dx Treatment is alpha-gal avoidance diet

1

10

50

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Addressing #Healthcare_maintenance of pts with #IBD is as important as managing disease activity! Our new review @SpringerNature in #current_treatment_options_in_gastroenterology with @FarrayeIBD #michaelpicco

0

14

47

Jana G Hashash, MD, MSc

@JHashashMD

3 years

More work needed to determine if & who we should screen? @AliTaherMD @nourmoukalled @AUBMC_Official Pts with IBD are at 3X higher incidence rate for VTE compared to general pop Rate increases to 8X when IBD is active Multiple hypotheses explaining increased risk of thrombosis

0

4

49

Jana G Hashash, MD, MSc

@JHashashMD

1 year

🖨️📢 #Vedolizumab is comparable to #antiTNF tx in mgmt of steroid refractory #microscopic_colitis @NabilElHageChe2 @DarrellPardi @FarrayeIBD @SGhoneimGI @jcg Efficacy and Safety of Vedolizumab and Tumor Necrosis... : Journal of Clinical Gastroenterology

Efficacy and Safety of Vedolizumab and Tumor Necrosis... : Journal of Clinical Gastroenterology

oid-refractory microscopic colitis. Methods: Retrospective studies and case series involving patients with steroid-refractory MC who either received vedolizumab, adalimumab, or infliximab were...

journals.lww.com

0

13

48

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Our review on #CVID in @AmJGastro with @JDSquire_MD @Marylandibddoc @FarrayeIBD #FFrancis @BinionMd #CVID is common Mimics #IBD #celiac etc #Infec 🦠➕ #noninfec cx Dx: History 📝 🤧🤕+ ⬇️ IgG Tx: Ig, sxic tx, & pred/steroid sparing 💉💊 Manage w All/Imm

An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic...

Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency. It is characterized by impaired B-cell differentiation. Although patients can be diagnosed with CVID...

pubmed.ncbi.nlm.nih.gov

1

10

49

Jana G Hashash, MD, MSc

@JHashashMD

6 months

🔊 @AmerGastroAssn CPU in @AGA_CGH on: ➡️ malignancy related to #IBD and #IBD meds 💊💉 ➡️ 🤔 what to do if pts with #IBD develop a malignancy ➡️ 🤔 what IBD related therapy to start in pts with history of malignancy @DrJordanAxelrad @ShirleyCoMekMD

0

17

49

Jana G Hashash, MD, MSc

@JHashashMD

1 year

Attending @AmCollegeGastro in Vancouver 🇨🇦? Join us for an all 🌟 panel at the Career Opportunities for Women in GI luncheon!!

2

7

47

Jana G Hashash, MD, MSc

@JHashashMD

1 year

🔊New podcast: Endoscopy for recurrent acute and chronic pancreatitis ⁦ @AmerGastroAssn ⁩ ⁦ @AGA_Gastro ⁩ Discussion points: 💠EUS and/or MRI postpancreatitis? 💠ERCP/endotherapy for panc divisum and pancreatitis? 💠surgery vs panc endotherapy?

New podcast: Endoscopy for recurrent acute and chronic pancreatitis

Four experts share what you need to know about the role of endoscopy for recurrent acute and chronic pancreatitis.

gastro.org

1

9

48

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Our correspondence in @LancetGastroHep on the unfortunate situation in Lebanon and what our #IBD patients and physicians are currently going through @AUBMC_Official

The Lancet Gastroenterology & Hepatology

@LancetGastroHep

3 years

New Correspondence - Fadi Mourad & Jana Hashash - Inflammatory bowel disease in #Lebanon : a plea for help #IBD #inflammatoryboweldisease #GITwitter

1

11

30

0

7

45

Jana G Hashash, MD, MSc

@JHashashMD

4 years

How to evaluate & manage pts w/ seronegative enteropathies @AGA_Gastro by experts @CeliacDoc @BenjaminLebwohl #AlbertoRubioTapia #FedericoBiagi #AGA_CPU @AGA @AasmaShaukatMD 💎Review histology w/ GI pathology 💎Serologic tests are essential 💎Carefully review diet, meds, travel

0

9

45

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Thanks to #SanjayMurthy @DrJFeuerstein @GeoffCNguyen & @Realcecum for an extremely practical #AGA_CPU #ExpertReview on Endoscopic Surveillance/Mgmt of Colorectal #Dysplasia in #IBD @AmerGastroAssn @AGA_Gastro @AndrewWangMD

2

10

44

Jana G Hashash, MD, MSc

@JHashashMD

1 year

💎Adequate stomal care=✅clinical outcomes 💎Ileostomy vs colostomy ➡️ ileo easier to construct/reverse ➡️ ileo more dehydration&skin excoriation 💎 High ostomy output: >1.5L/d ⁦ @ShirleyCoMekMD ⁩ ⁦ @JillGaidosMD ⁩ ⁦ @AmerGastroAssn ⁩ ⁦ @AndrewWangMD ⁩

0

10

42

Jana G Hashash, MD, MSc

@JHashashMD

4 years

So excited about our new paper published in @AGA_CGH : Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults with Crohn's Disease: An Exploratory O… @MRegueiroMD @BinionMd Eva Szigethy

Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn's Disease:...

A stepped-care approach shows that we can improve sleep disturbance with BBTS-I in CD patients, but fatigue only partially improves. For a subset of patients who chose to add BUP-SR to their behavi...

pubmed.ncbi.nlm.nih.gov

0

12

42

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Thank you ⁦ @IBDConference ⁩ for reconnecting friends over a great #AIBD2021 meeting. This photo took me back 5+ years when we were all ⁦ @PittGILiverNutr ⁩! ⁦ @MRegueiroMD ⁩ ⁦⁦ @SCKimCHP ⁩

0

1

41

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Great @AmCollegeGastro #WomenInGI committee mtg under the leadership of the inspirational @ShivangiKMD ! @jensemineriomd @Lavanyamd @TrieuMD @ibdgijami @swapnagayam @MarkPochapin @ShimaghavimiMD @kehutchins77 @AKhapraMD @Neena_MD @UzmaSiddiquiMD @DianaLSnyderMD @GastroHealthDoc

5

7

41

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Our paper on Positioning Biologics in the Management of Moderate to Severe CD in Current Opinion in Gastroenterology Consider these factors when picking biologic to use: 💎 Fistula 💎 Risk for serious infx/Malignancy 💎 Age 💎 EIM 💎 Disease extent

0

11

41

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Check out our paper: Approach to Latent Tuberculosis Infection Screening Before Biologic Therapy in IBD Patients: PPD or IGRA? @MRegueiroMD @IBDJournals

Approach to Latent Tuberculosis Infection Screening Before Biologic Therapy in IBD Patients: PPD or...

The use of biological agents for the treatment of chronic inflammatory conditions such as inflammatory bowel diseases (IBD) has been on the rise.1,2 Current biological therapies include antitumor...

pubmed.ncbi.nlm.nih.gov

2

6

39

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Are the New Biologics Effective in the Management of Postoperative Crohn’s Disease? | Inflammatory Bowel Diseases | Oxford Academic ➡️ vedo & uste play a role in mgmt of postop CD ➡️ Definite positioning remains to be determined (check our algorithm)

Are the New Biologics Effective in the Management of Postoperative Crohn’s Disease?

AbstractBackground. Despite the growing therapeutic armamentarium, at least half of the patients with Crohn’s disease will require surgery during their lif

academic.oup.com

2

8

38

Jana G Hashash, MD, MSc

@JHashashMD

3 years

What a great way to kick off the @MayoClinicGIHep meeting with @FarrayeIBD discussing #CD Treatment Landscape in #2022 . Looking forward to learning more over the coming few days. @williampalmermd @SLHanselMD @RahulPannala

0

2

39

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Hot off the press! Use & Misuse of PN in Pts with #IBD 🗒Screen for malnutrition at diagnosis and periodically after 🚩 BMI<18.5, unintentional ⬇️ wt, ⬇️ muscle mass 🚩 Pt with ⬇️ food consumption, impaired assimilation of nutrients & inflammation Working with dietician is 🔑

1

10

38

Jana G Hashash, MD, MSc

@JHashashMD

2 years

What an incredible honor to host this @AmerGastroAssn podcast on lifestyle modification in #NAFLD 💠 Prev of NAFLD is ⬆️ing 💠 Risk stratify pts using noninvasive tests (FIB-4, transient elastography, etc) 💠 Individualize lifestyle modifications (diet 🥗, exercise🏋️, wt loss)

American Gastroenterological Association (AGA)

@AmerGastroAssn

2 years

🎙️We dropped a new episode of Inside Scope! Listen to our special episode on helping patients with #NAFLD lose weight hosted by Drs. @JHashashMD featuring @AndrewWangMD & @Pattonhm1 🎧 Available wherever you listen to podcasts. #GITwitter

1

2

9

1

4

37

Jana G Hashash, MD, MSc

@JHashashMD

11 months

AGA Rapid CPU on Management of Patients Taking GLP-1 RA Prior to Endoscopy ✅Individualize approach 🧐Evidence needed to inform practice 👉Consider liquids day before ⁦ @AGA_CGH ⁩ ⁦ @AndrewWangMD ⁩ ⁦ @MetabolicEndo ⁩ ⁦ @AmerGastroAssn ⁩

1

13

35

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Great catching up with colleagues from the @MayoClinic after the #IBD session of the #MAYOGIH2023 course

0

5

35

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Join @AmCollegeGastro VGR to hear our star ⭐️ panelists discuss Career Opportunities for Women in GI on Sept 14th 8.30-10pm ET — with @LinChangMD @AasmaShaukatMD @drdani23 @DrShireenPais @Lavanyamd @julietobak #vondareeves #kumkumpatel

0

8

33

Jana G Hashash, MD, MSc

@JHashashMD

4 years

It's always great to discuss cases with colleagues on @ibdlive with @MRegueiroMD @BinionMd @FarrayeIBD @DrSamirAShah1 @roniaoun @askIBDdoc @DCharabaty @AUBMC_Official @AUB_Lebanon

1

4

33

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Granuloma on bx in Crohn’s disease was associated with ⬆️ intra-abdominal abscesses/fistula and ⬆️ immunomodulator/immunosuppressive therapy @FarrayeIBD @IBD_Afzali @DCharabaty @AUBMC_Official @AUB_Lebanon @MayoClinicGIHep @ibdgijami @MRegueiroMD

Hisham Wehbe

@HishamWehbeMD

2 years

📣Thrilled to announce our new publication on the significance of granulomas in the outcomes of CD ‼️ Granulomas were significantly associated with development of intra-abdominal abscesses &/or fistulas and ⬆️ use of immunomodulators & suppressors💊 #MedTwitter #GItwitter #MedEd

10

7

99

1

0

31

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Excited to share our review by @roniaoun @JabakSuha @MRegueiroMD #FadiMourad that was just published in @JCGjournal First or Second Biologic in Inflammatory Bowel Disease: Combination Therapy or Monotherapy?

First or Second Biologic in Inflammatory Bowel Disease: Combination Therapy or Monotherapy? - PubMed

The therapeutic armamentarium for patients with inflammatory bowel disease has been expanding. Current guidelines make recommendations about whether patients who are biologic naive should be receiv...

pubmed.ncbi.nlm.nih.gov

0

6

31

Jana G Hashash, MD, MSc

@JHashashMD

7 months

Alpha-gal syndrome ➡️ IgE-med rxn post ingesting mammalian product 🍔🥩🥛🧀 GI alpha gal=abd pain, 🤢/🤮, ⬆️💩 History is 🔑 for dx Alpha-gal Ig-E Abs support dx Treat: avoidance diet @AmerGastroAssn @AGA_CGH @SarahMcGillMD @AndrewWangMD @alphagal_info @AlphaGal_RES

American Gastroenterological Association (AGA)

@AmerGastroAssn

7 months

🎧🎤Take a listen to our latest podcast episode featuring a discussion with alpha-gal CPU authors so you know what signs and symptoms to be on the lookout for. Thank you @JHashashMD @SarahMcGillMD and Drs. Thomas Platts-Mills and Hannah Dodson.

2

10

31

1

6

30

Jana G Hashash, MD, MSc

@JHashashMD

3 years

The⁩ ⁦ @MayoClinicGIHep ⁩ FL #IBD team during ⁦ @CrohnsColitisFn ⁩ ⁦ @takesteps ⁩ 2022 with ⁦ @ibdgijami ⁩ ⁦ @FarrayeIBD ⁩ ⁦ @DonnaShelton4 ⁩ ⁦ @kristinclift ⁩

1

4

30

Jana G Hashash, MD, MSc

@JHashashMD

3 years

📢 We are accepting #AdvancedIBD fellowship applications @MayoClinic @MayoClinicGIHep in FL for 7/2022. ✅Excellent clinical experience, ✅research opportunities, and a ✅phenomenal team: @FarrayeIBD #michaelpicco @DonnaShelton4 #tammyvann #kaitlynmyatt and @ibdgijami very soon

Mayo Clinic Gastroenterology & Hepatology

@MayoClinicGIHep

3 years

A 1yr adv IBD fellowship is open @MayoClinic in Jacksonville, Fl to begin 7/22. The program includes extensive training in the in/outpatient mgmt of pts w/complicated IBD & performing endoscopy as well as time to complete a research project. @FarrayeIBD

0

6

16

1

5

28

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Had the honor of speaking at the #IBD session of the ⁦ @AmCollegeGastro ⁩ #FGS meeting this morning and connecting with friends over science ⁦ @ibddocmaria ⁩ ⁦ @IBD_Afzali ⁩ ⁦ @jensemineriomd ⁩ ⁦ @AsadurRahman87 ⁩ ⁦ @TolgaErim ⁩ ⁦ @BMoshiree ⁩

0

3

28

Jana G Hashash, MD, MSc

@JHashashMD

2 months

🔊 Do you have a clinical question where more guidance is needed? There’s a call for topics for @AmerGastroAssn Clinical Practice Updates (CPUs) for pub consideration in @AGA_Gastro or @AGA_CGH Topic suggestion form @ or email clinicalpractice @gastro .org

1

9

28

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Incredibly honored and humbled to be receiving the @aubmcshbpp #AUB Faculty of Medicine Humanism and Professionalism Physician Award @AUBMC_Official this year

SHBPP-AUBFM

@aubmcshbpp

3 years

0

3

1

26

Jana G Hashash, MD, MSc

@JHashashMD

4 years

AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review @AmerGastroAssn @AGA_CGH @AasmaShaukatMD #AGA_CPU

AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management:...

The evidence reviewed in this manuscript is a summation of relevant scientific publications, expert opinion statements, and current practice guidelines. BEST PRACTICE ADVICE 1: With the rising...

pubmed.ncbi.nlm.nih.gov

0

10

26

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Great day with @MayoClinicGIHep FL #IBD team @CrohnsColitisFn #TakeSteps2021 @FarrayeIBD @DonnaShelton4

0

3

25

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Thank you @IBD_Afzali for an amazing talk this morning @MayoClinicGIHep #FL about #PrecisionMedicine in #IBD @FarrayeIBD @ibdgijami

0

25

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Great presentation by #KMotwani highlighting our work on “Impact of Holding Immunosuppressive Therapy in Pts with IBD around time of mRNA COVID Vaccination” CONCLUSION: Continue IBD tx 💊 without interruption while receiving mRNA COVID-19 vaccine 💉 @AmCollegeGastro #ACG2022

0

7

23

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Learning from Master #IBD physician-scientist ⁦ @ibddocmaria ⁩ at ⁦ @AmCollegeGastro ⁩ ⁦ @FLGastroSociety ⁩ with ⁦ @IBD_Afzali ⁩ ⁦ @jensemineriomd ⁩ ⁦ @TolgaErim ⁩ ⁦⁦⁦ @AmerGastroAssn ⁩

0

3

23

Jana G Hashash, MD, MSc

@JHashashMD

1 year

Alpha-gal syndrome ➡️ IgE-med rxn post ingesting mammalian product 🍔🥩🥛🧀 GI alpha gal=abd pain, 🤢/🤮, ⬆️💩 History is 🔑 for dx Alpha-gal Ig-E Abs support dx Treat: avoidance diet ⁦ @SarahMcGillMD ⁩ ⁦ @AmerGastroAssn ⁩ ⁦ @AndrewWangMD ⁩

Clinical Practice Update: How to know if a tick bite caused your...

Watch AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician: Commentary co-authors Drs. Jana Al-Hashash and Sarah McGill chat about how to ...

www.youtube.com

0

3

24

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Very useful table from Shmais et al’s review on ‘Proactive vs Reactive TDM in IBD’ #inflammintestdiseases @GastroKarger @ShmaisManar @MRegueiroMD

0

6

24

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Fantastic talk @FarrayeIBD on #dysplasia in #IBD @DDWMeeting #AGA_CPU : Refer to surgery if: 💠endoscopically invisible dysplasia 💠endoscopically unresectable lesion 💠multifocal low grade dysplasia 💠difficult to manage IBD and any dysplasia grade

0

6

20

Jana G Hashash, MD, MSc

@JHashashMD

3 years

What a great #AGA_CPU on Management of Bleeding Gastric Varices @AGA_CGH @AmerGastroAssn @AasmaShaukatMD which includes 💎Excellent best practice advice 💎Algorithm for mgmt of suspected pHTN bldg 💎Algorithm for GV bldg 💎Recommended method for CA therapy

1

10

23

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy? @MRegueiroMD @JabakSuha @IBDJournals

0

3

22

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Keep an eye out for upcoming #AGA_CPUs after a fantastic mtg w/ @AmerGastroAssn Pres @InadomiJ , Chair #AndyWang & team @ShailjaShahMD @seth_crockett @AndyChanMD @SultanShazi #michaelkochman @IssakaMD #cynthiako #kathrynpeterson #anabuchner #dennisyang #josephahn #albertorubiotapia

0

3

21

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Experts @ShailjaShahMD @PrasadIyerMD & #StevenMossMD publish an #AGA_CPU on Management of Refractory H. pylori in @AGA_Gastro @AmerGastroAssn @AasmaShaukatMD 💠Be aware of antibiotic resistance 💠Shared decision making is important 💠Longer treatment duration is better

0

10

22

Jana G Hashash, MD, MSc

@JHashashMD

5 years

Amidst all the stress and uncertainty, happy to share our manuscript on the role of abnormal MUC1 expression as a biomarker for postoperative Crohn’s disease recurrence @MRegueiroMD @BinionMd

Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative...

MUC1 is overexpressed and hypoglycosylated in neo-terminal ileum tissue of patients with postoperative CD recurrence. Increased levels are associated with more severe endoscopic recurrence scores,...

pubmed.ncbi.nlm.nih.gov

0

5

22

Jana G Hashash, MD, MSc

@JHashashMD

4 years

IBD in Lebanon on the rise - @IBDConference @kimrzakka @martinebejjani @MarilyneDaher1

Kimberley Zakka, MD, MSc

@kimrzakka

4 years

Check out our descriptive study on inflammatory bowel disease in Lebanon #AIBDconference2020 #IBD #crohns #ulcerativecolitis Many thanks to our awesome PI and mentor Dr. Hashash @JHashashMD

0

6

0

2

21

Jana G Hashash, MD, MSc

@JHashashMD

4 years

#AGA_CPU on Lifestyle Modification Using Diet & Exercise to Achieve Weight Loss in Mgmnt of NAFLD @AGA_Gastro @AmerGastroAssn @AasmaShaukatMD 💠150-300 mins moderate or 75-150 mins vigorous-intensity aerobic exercise/wk 💠Diet:1200-1500 kcal/d 💠R/O co-metabolic dx 💠🛑Stop🍷🍺

1

10

20

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Hot off the press: AGA CPU on Bariatric Surgery in #Cirrhosis in @AGA_CGH @AmerGastroAssn #AGA_CPU @JulieHeimbach @AasmaShaukatMD 💠 Obesity in cirrhosis is a RF for complications 💠Individualize method & rapidity for losing excess body fat

0

3

20

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Do Kidney Transplant Medications Supplant IBD Drugs? | MedPage Today Study by ⭐️ IBD fellow @mariannysulbar ⁩ -50% CD on IS for renal tx did not require add’l biologics - Adding biologic tx ok after d/w tx team ⁦ @FarrayeIBD ⁩ ⁦ @ibdgijami ⁩

Do Kidney Transplant Medications Supplant IBD Drugs?

Study shows many patients no longer need drugs to help keep gut disease in check

www.medpagetoday.com

2

19

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Great SIBO update from experts #eamonnquigley , @josephmurrayMD and @MarkPimentelMD in AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review #AGA_CPU @AmerGastroAssn @AGA_Gastro @AasmaShaukatMD

0

2

18

Jana G Hashash, MD, MSc

@JHashashMD

1 year

#AGAgastrosquad

Jami Kinnucan, MD, FACG, AGAF, FCCF

@ibdgijami

1 year

Starting now! Come chat with us @MLongMD @JHashashMD @AmerGastroAssn @JosephHabibi_MD @DDWMeeting

0

2

30

0

18

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Thank you @IBDConference for the opportunity to present alongside @Hherf @RPanaccione @EdwardLoftus2 on PSC/IBD. @MRegueiroMD @MLongMD #AIBDAmbassador

1

2

17

Jana G Hashash, MD, MSc

@JHashashMD

2 years

Incredibly honored to have been part of this work under the leadership of Prof #MarwanElSabban @AUB_Lebanon Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disea… @ShirinianM @AUBMC_Official

Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflam...

These results suggest that TET-2 expression levels, as well as Cx43 expression levels, are modulated in models of intestinal inflammation. We hypothesize that TET-2 may demethylate genes involved in...

pubmed.ncbi.nlm.nih.gov

0

17

Jana G Hashash, MD, MSc

@JHashashMD

2 years

⁦Great place to find all ⁦ @AmerGastroAssn ⁩ CPUs and guidelines on ONE platform!! ⁦ @AGA_Gastro ⁩ ⁦ @AGA_CGH ⁩ ⁦ @AndrewWangMD ⁩ ⁦ @SultanShazi ⁩ Clinical Guidance - American Gastroenterological Association

Clinical Guidance

Need help treating a digestive condition? Access AGA's free GI clinical guidelines on IBD and bowel disorders, colorectal cancer and more.

gastro.org

0

1

14

Jana G Hashash, MD, MSc

@JHashashMD

2 years

📣 Hot off the 🖨 — Our paper w/ @DanielaFluxa @FarrayeIBD #BRoussel on Health Maintenance in #IBD @RIMedJournal 💉vaccines 🩻bone health 🔎screening - ca, mental health Preventive Care and Health Maintenance in Patients with Inflammatory Bowel Disease.

Preventive Care and Health Maintenance in Patients with Inflammatory Bowel Disease - PubMed

Health maintenance in patients with inflammatory bowel disease (IBD) is essential. In order to achieve clinical and endoscopic remission, many patients will require treatment with steroids, immunom...

pubmed.ncbi.nlm.nih.gov

0

2

13

Jana G Hashash, MD, MSc

@JHashashMD

3 years

On-site 🏥 Availability ⬆️ Vaccination Rates @IBDJournals @FarrayeIBD @Badr_AlBawardy @MRegueiroMD @moss_md

On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease

Vaccines play a crucial role in preventing several infections in patients with inflammatory bowel diseases (IBDs) and an important aspect of preventative c

academic.oup.com

0

5

14

Jana G Hashash, MD, MSc

@JHashashMD

4 years

All you need to know about managing diverticulitis 💠Abx selectively rather than routinely in immunocompetent pts w/ mild uncomplicated diverticulitis 💠~50% of risk for diverticulitis is attributable to genetic factors @AGA_Gastro @AmerGastroAssn #AGA_CPU @AasmaShaukatMD

0

4

13

Jana G Hashash, MD, MSc

@JHashashMD

1 year

Join us for ⁦ @AmerGastroAssn ⁩ CPU Battle of the heavyweights! ⁦ @AndrewWangMD ⁩ ⁦ @AndyChanMD ⁩ ⁦ @laura_targownik ⁩ ⁦ @DrJFeuerstein ⁩ #AGAgastrosquad

0

1

11

Jana G Hashash, MD, MSc

@JHashashMD

4 years

Important commentary on Reducing Rates of Post-Endosocpy Esophageal Adenocarcinoma. @AGA_Gastro #AGA_CPU @AmerGastroAssn @AasmaShaukatMD . Most Post-endoscopy EACs (PEECs) result from missed lesions: “Look more and biopsy appropriately”.

0

11

Jana G Hashash, MD, MSc

@JHashashMD

3 years

So happy to be part of this project with @AmanBaliMD @FarrayeIBD #michaelpicco & @thomaskroner from @MayoClinicGIHep FL, published in @IBDJournals Time-to Flexible Sigmoidoscopy or Colonoscopy in Pts Admitted with #UC has Decreased from 2012 to 2018

Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has...

AbstractBackground. Early endoscopic evaluation of patients with ulcerative colitis (UC) enables assessment of disease activity and accurate diagnosis base

academic.oup.com

0

4

9

Jana G Hashash, MD, MSc

@JHashashMD

10 months

@DuekerJeffrey @fudmanMD @DCharabaty @MondayNightIBD @TakedaPharma @JanssenUS @abbvie @BettenworthDb @P_DeepakIBDMD @BenClickMD @puentesfabi @KralJan @jalpa_devi @JeremyAdlerMD @ShaziaMSiddique @IBDBen @Realcecum @EdwardLoftus2 @GKochharMD @KofiClarkeMD @ManasiAgrawalMD @DhereMdEmory @Waseem_AhmedMD @tqaziMD @ShirleyCoMekMD @berinsj We showed fecal cal is also sensitive and specific in ileal CD:

Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small...

AbstractBackground. Severe Crohn’s disease [CD] can result in extensive bowel resections and need for creation of an ileostomy. Faecal calprotectin [FC] is

academic.oup.com

1

10

Jana G Hashash, MD, MSc

@JHashashMD

4 years

@IBD_FloMD @IBDConference @MRegueiroMD @MLongMD @NMH_SHanauerMD @IBD_Afzali @ibddoctor @Hherf @moss_md @LauraRaffalsMD @pakotze @PhilFleshnerMD Can’t wait to join you all from Lebanon 🇱🇧 @YazbeckNadine @JabakSuha @roniaoun @ShmaisManar @TarekNammour

0

1

10

Jana G Hashash, MD, MSc

@JHashashMD

4 years

All what you need to tell your patients to reduce their risk of developing colon polyps/CRC in this #AGA_CPU by experts @AasmaShaukatMD @seth_crockett @petersliang just published in @AGA_CGH @AmerGastroAssn

0

3

10

Jana G Hashash, MD, MSc

@JHashashMD

2 years

@UpToDate @AUBMC_Official Tagging the one and only inspirational scientist and clinician @AliTaherMD

1

10

Jana G Hashash, MD, MSc

@JHashashMD

2 years

#SRMA on #FMT in #UC ⁦ @IBDJournals ⁩ FMT➡️CLINICAL & ENDO benefit in short term tx of UC Safety FMT=placebo ⁦ @NabilElHageChe2 ⁩ ⁦ @SGhoneimGI ⁩ ⁦ @FarrayeIBD ⁩ ⁦ @AUBMC_Official ⁩ ⁦ @MayoClinicGIHep ⁩ ⁦ @PittGILiverNutr ⁩

1

2

9

Jana G Hashash, MD, MSc

@JHashashMD

3 years

@JosephHabibi_MD @DCharabaty @AmCollegeGastro @HealioGastro @MarcelYibirin @VictorChedidMD @ealkazzi @Natalie_Farha @RomyChamoun @JPAchkarMD I’ll be there! @DCharabaty - let’s plan a Lebanese in GI get together! PS: @JosephHabibi_MD : aren’t you also excited to see the old Lebanese physicians? 😞😂

1

0

9

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Welcoming the one and only @AndrewWangMD , Chair of our @AmerGastroAssn #AGA_CPU committee, to #MedTwitter ! @InadomiJ @LinChangMD @AGA_Gastro @AGA_CGH @seth_crockett @ShailjaShahMD @AndyChanMD @MedicineUVA

0

7

Jana G Hashash, MD, MSc

@JHashashMD

3 years

SRMA shows Evidence supporting protective effect of aspirin resumption soon after NVUGIB is low-to-moderate certainty, and not informative as to optimal timing of aspirin resumption @AUBMC_Official #AnnalsGastroenterol @Elie__Akl @AssemMKhamis @roniaoun Editor: @IoannisKoutroub

Roni Aoun

@roniaoun

3 years

What do we know about the effects of aspirin resumption following non-variceal upper GI bleeding? Check out our newly published article. Proud to be part of this great team! @JHashashMD @Elie__Akl @AssemMKhamis

0

1

5

0

1

7

Jana G Hashash, MD, MSc

@JHashashMD

3 years

@IBD_FloMD There are currently 4 IFX biosimilars approved for #IBD in the US and 6 approved ADA biosimilars. #AGAExpertX

0

6

Jana G Hashash, MD, MSc

@JHashashMD

3 years

@IBD_FloMD A9/Although data are limited, multiple switches of #biosimilars in #IBD are acceptable. In a recently published prospective multicenter cohort study, multiple switches from originator IFX to biosimilars was effective & safe in pts w #IBD (IBDj. 2021 May 20;izab099). #AGAExpertX

0

4

6

Jana G Hashash, MD, MSc

@JHashashMD

2 years

@DCharabaty @RomyChamoun @KaazanPatricia @JosephHabibi_MD @VictorYazbeck @PascalJabbourMD @VictorChedidMD @eliekozaily1 @GIcancerDoc @RamiKantar1 Love @DCharabaty ‘s purse and @JosephHabibi_MD ‘s bracelet!! Most of all and like you all: LOVE ❤️ Lebanon 🇱🇧

0

6

Jana G Hashash, MD, MSc

@JHashashMD

3 years

@IBD_FloMD A8/ Emerging data on #biosimilars continue to reassure patients and their physicians about the safety and efficacy of these medications in treating patients with IBD. Emerging data is supporting reverse and multiple switches. #AGAExpertX

0

3

6

Jana G Hashash, MD, MSc

@JHashashMD

3 years

Join us on 12/7 4:30pm ET to discuss #biosimilar use in #IBD with @IBD_FloMD @ibdgijami @Marylandibddoc @GI_PharmD @IBD_Afzali @AmerGastroAssn

American Gastroenterological Association (AGA)

@AmerGastroAssn

3 years

9/ If you enjoyed this #AGAExpertX join us: 🗓️LIVE Twitter Chat 12/7 4:30pm ET w/ @ibdgijami @IBD_FloMD @Marylandibddoc @GI_PharmD @JHashashMD @IBD_Afzali 🎙️ #biosimilar use in #IBD ▪️Review clinical efficacy, safety data ▪️Challenges in adoption ▪️Why does this all matter?

0

4

6

0

4

6

Jana G Hashash, MD, MSc

@JHashashMD

2 years

🔊Congratulations to our @AmerGastroAssn Clinical Practice Update Committee chair, Professor @AndrewWangMD for becoming the new #Chief of Gastroenterology and Hepatology @UvaDOM !! Excellent leader, clinician, educator and master endoscopist.

UVA Department of Medicine

@UvaDOM

2 years

Congratulations to Andrew Wang, MD, Professor of Medicine, on his appointment as Chief for the Division of Gastroenterology and Hepatology. Please welcome Dr. Wang into this role, which he will assume as of July 1, 2022. @andrewwangmd @uvahealthnews

17

9

117

0

5

Jana G Hashash, MD, MSc

@JHashashMD

6 months

@JosephHabibi_MD @MaiaKayalMD @AmCollegeGastro @dunleavy_katie @BMoshiree @ReezwanaCMD @ALOliphant @DCharabaty @spaulliver @DrSamirAShah1 @ThereziaRD @GIdietitian @ownyourcrohns Yummy! 🤤 We eat them as soon as they’re cooked as if they’re peanuts!!! Even before they make it to the yogurt pan 😝 — I have some in my freezer in Pitt @JosephHabibi_MD — go get them!!

1

0

5